Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors

被引:66
作者
Appledorn, D. M. [1 ]
McBride, A. [1 ]
Seregin, S. [1 ]
Scott, J. M. [1 ]
Schuldt, N. [1 ]
Kiang, A. [2 ]
Godbehere, S. [1 ]
Amalfitano, A. [1 ,2 ,3 ]
机构
[1] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48823 USA
[2] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[3] Michigan State Univ, Dept Pediat, E Lansing, MI 48823 USA
基金
美国国家卫生研究院;
关键词
vaccine; innate immunity; complement system; alternative pathway; classical pathway;
D O I
10.1038/gt.2008.114
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The complement system is known to play critical roles in pathogen identification, initiation of innate immune responses and facilitation of adaptive immune responses. Several studies have suggested that recombinant adenoviruses (rAds) interact with proteins of the complement system within minutes of administration. In this study, we assessed the roles of the alternative (Factor B), classical (C1q and C4) and common (C3) arms of the complement system in the innate and humoral response to systemic rAd administration using mice genetically deficient for each of these functions. Although most plasma cytokines and chemokines induced by Ads appeared to be elicited in a C3-dependent manner, we found that rAd-induced thrombocytopenia was dependent on Factor B and C3, implicating the alternative pathway as responsible for this response. Alteration of the complement-dependent transcriptome response after rAd-induced liver gene expression was also found to be Factor B- and C3- dependent. Ad interactions with the classical and alternative arms of the complement system can also be redundant, as many complement-dependent, Ad-induced innate immune responses appeared to be primarily C3- dependent. We also identified a C3 dependence of Ad-mediated induction of the nuclear factor-kappa B (NF-kappa B) activation pathway. Finally, we confirmed that humoral immune responses to the vector capsid, and the transgene it encodes, are also complement-dependent.
引用
收藏
页码:1606 / 1617
页数:12
相关论文
共 48 条
[1]
Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted [J].
Amalfitano, A ;
Hauser, MA ;
Hu, HM ;
Serra, D ;
Begy, CR ;
Chamberlain, JS .
JOURNAL OF VIROLOGY, 1998, 72 (02) :926-933
[2]
Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent [J].
Appledorn, D. M. ;
Kiang, A. ;
McBride, A. ;
Jiang, H. ;
Seregin, S. ;
Scott, J. M. ;
Stringer, R. ;
Kousa, Y. ;
Hoban, M. ;
Frank, M. M. ;
Amalfitano, A. .
GENE THERAPY, 2008, 15 (12) :885-901
[3]
APPLEDORN DM, 2008, J IMMUNOL IN PRESS
[4]
The role of complement in inflammation and adaptive immunity [J].
Barrington, R ;
Zhang, M ;
Fischer, M ;
Carroll, MC .
IMMUNOLOGICAL REVIEWS, 2001, 180 :5-15
[5]
Vaccination with replication-deficient recombinant adenoviruses encoding the main surface antigens of Toxoplasma gondii induces immune response and protection against infection in mice [J].
Caetano, BC ;
Bruña-Romero, O ;
Fux, B ;
Mendes, EA ;
Penido, MLO ;
Gazzinelli, RT .
HUMAN GENE THERAPY, 2006, 17 (04) :415-426
[6]
The complement system in regulation of adaptive immunity [J].
Carroll, MC .
NATURE IMMUNOLOGY, 2004, 5 (10) :981-986
[7]
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector [J].
Catanzaro, Andrew T. ;
Koup, Richard A. ;
Roederer, Mario ;
Bailer, Robert T. ;
Enama, Mary E. ;
Moodie, Zoe ;
Gu, Lin ;
Martin, Julie E. ;
Novik, Laura ;
Chakrabarti, Bimal K. ;
Butman, Bryan T. ;
Gall, Jason G. D. ;
King, C. Richter ;
Andrews, Charla A. ;
Sheets, Rebecca ;
Gomez, Phillip L. ;
Mascola, John R. ;
Nabel, Gary J. ;
Graham, Barney S. .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (12) :1638-1649
[8]
Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors [J].
Cerullo, Vincenzo ;
Seiler, Michael P. ;
Mane, Viraj ;
Brunetti-Pierri, Nicola ;
Clarke, Christian ;
Bertin, Terry K. ;
Rodgers, John R. ;
Lee, Brendan .
MOLECULAR THERAPY, 2007, 15 (02) :378-385
[9]
Complement activation by recombinant adenoviruses [J].
Cichon, G ;
Boeckh-Herwig, S ;
Schmidt, HH ;
Wehnes, E ;
Müller, T ;
Pring-Akerblom, P ;
Burger, R .
GENE THERAPY, 2001, 8 (23) :1794-1800
[10]
Liver Toxicities typically induced by first-generation adenoviral vectors can be reduced by use of E1, E2b-deleted adenoviral vectors [J].
Everett, RS ;
Hodges, BL ;
Ding, EY ;
Xu, F ;
Serra, D ;
Amalfitano, A .
HUMAN GENE THERAPY, 2003, 14 (18) :1715-1726